View in EDS HTML Full Text PDF Full Text

Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.

Saved in:
Bibliographic Details
Title: Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Authors: Åkerblom A; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden. Axel.Akerblom@ucr.uu.se.; Uppsala Clinical Research Center UCR, Uppsala University, Uppsala, Sweden. Axel.Akerblom@ucr.uu.se.; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA. Axel.Akerblom@ucr.uu.se.; Uppsala Clinical Research Center, Dag Hammarskjölds väg 38, 751 85, Uppsala, Sweden. Axel.Akerblom@ucr.uu.se., Wojdyla D; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA., Steg PG; INSERM-Unité 1148, Paris, France.; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France.; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France.; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, UK., Wallentin L; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Center UCR, Uppsala University, Uppsala, Sweden., James SK; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Center UCR, Uppsala University, Uppsala, Sweden., Budaj A; Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland., Katus HA; Medizinishe Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany., Himmelmann A; AstraZeneca Research and Development, Mölndal, Sweden., Huber K; Department of Cardiology and Intensive Care Medicine, Wilhelminen Hospital, Vienna, Austria.; Medical School, Sigmund Freud University, Vienna, Austria., Siegbahn A; Uppsala Clinical Research Center UCR, Uppsala University, Uppsala, Sweden.; Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden., Storey RF; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Becker RC; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.; Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, Academic Health Center, Cincinnati, OH, USA.
Corporate Authors: PLATO Investigators
Source: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2019 Nov; Vol. 48 (4), pp. 563-569.
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9502018 Publication Model: Print Cited Medium: Internet ISSN: 1573-742X (Electronic) Linking ISSN: 09295305 NLM ISO Abbreviation: J Thromb Thrombolysis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31512201
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Åkerblom+A%22">Åkerblom A</searchLink>; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden. Axel.Akerblom@ucr.uu.se.; Uppsala Clinical Research Center UCR, Uppsala University, Uppsala, Sweden. Axel.Akerblom@ucr.uu.se.; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA. Axel.Akerblom@ucr.uu.se.; Uppsala Clinical Research Center, Dag Hammarskjölds väg 38, 751 85, Uppsala, Sweden. Axel.Akerblom@ucr.uu.se.<br /><searchLink fieldCode="AU" term="%22Wojdyla+D%22">Wojdyla D</searchLink>; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Steg+PG%22">Steg PG</searchLink>; INSERM-Unité 1148, Paris, France.; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France.; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France.; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Wallentin+L%22">Wallentin L</searchLink>; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Center UCR, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22James+SK%22">James SK</searchLink>; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Center UCR, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Budaj+A%22">Budaj A</searchLink>; Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Katus+HA%22">Katus HA</searchLink>; Medizinishe Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Himmelmann+A%22">Himmelmann A</searchLink>; AstraZeneca Research and Development, Mölndal, Sweden.<br /><searchLink fieldCode="AU" term="%22Huber+K%22">Huber K</searchLink>; Department of Cardiology and Intensive Care Medicine, Wilhelminen Hospital, Vienna, Austria.; Medical School, Sigmund Freud University, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Siegbahn+A%22">Siegbahn A</searchLink>; Uppsala Clinical Research Center UCR, Uppsala University, Uppsala, Sweden.; Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Storey+RF%22">Storey RF</searchLink>; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Becker+RC%22">Becker RC</searchLink>; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.; Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, Academic Health Center, Cincinnati, OH, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22PLATO+Investigators%22">PLATO Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502018%22">Journal of thrombosis and thrombolysis</searchLink> [J Thromb Thrombolysis] 2019 Nov; Vol. 48 (4), pp. 563-569.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic+Publishers%22">Kluwer Academic Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9502018 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-742X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209295305%22">09295305 </searchLink><i>NLM ISO Abbreviation: </i>J Thromb Thrombolysis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31512201
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11239-019-01938-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 563
    Titles:
      – TitleFull: Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Åkerblom A
      – PersonEntity:
          Name:
            NameFull: Wojdyla D
      – PersonEntity:
          Name:
            NameFull: Steg PG
      – PersonEntity:
          Name:
            NameFull: Wallentin L
      – PersonEntity:
          Name:
            NameFull: James SK
      – PersonEntity:
          Name:
            NameFull: Budaj A
      – PersonEntity:
          Name:
            NameFull: Katus HA
      – PersonEntity:
          Name:
            NameFull: Himmelmann A
      – PersonEntity:
          Name:
            NameFull: Huber K
      – PersonEntity:
          Name:
            NameFull: Siegbahn A
      – PersonEntity:
          Name:
            NameFull: Storey RF
      – PersonEntity:
          Name:
            NameFull: Becker RC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2019 Nov
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1573-742X
          Numbering:
            – Type: volume
              Value: 48
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Journal of thrombosis and thrombolysis
              Type: main
ResultId 1